A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG/ Alliance Z5041 Trial
- Citation:
- J Clin Oncol vol 36 (15_suppl) 4112
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3037
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Alice Chia-chi Wei Fang-Shu Ou Qian Shi Eileen Mary O'Reilly Jeffrey A. Meyerhardt Robert A. Wolff Hedy L. Kindler Douglas B. Evans Vikram Deshpande Joseph Misdraji Eric P. Tamm Dushyant Sahani Malcolm J. Moore Elliot Newman Nipun B. Merchant Jordan Berlin Laura Williams Goff Peter W. T. Pisters Mitchell C. Posner
- Networks:
- 11030, FL028, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-TN008, LAPS-TX035, LAPS-WI013, NORTHWELL
- Study
- ACOSOG-Z5041
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: